The Changing Face of Pleural Empyemas in Children: Epidemiology and Management

Author:

Schultz Karen D.1,Fan Leland L.1,Pinsky Jay2,Ochoa Lyssa2,Smith E. O’Brian3,Kaplan Sheldon L.4,Brandt Mary L.2

Affiliation:

1. Department of Pediatrics, Pulmonology Section, Baylor College of Medicine Houston, Texas

2. Michael E. DeBakey Department of Surgery, Department of Pediatrics, Baylor College of Medicine Houston, Texas

3. Department of Pediatrics, Nutrition Section, Baylor College of Medicine Houston, Texas

4. Department of Pediatrics, Infectious Diseases Section, Baylor College of Medicine Houston, Texas

Abstract

Objective. Empyema remains a significant cause of morbidity in children. This study evaluates the changes that have affected the outcome in children with pleural empyema, including the emergence of resistant organisms, the introduction of the pneumococcal conjugate vaccine, and earlier treatment with video-assisted thoracoscopy (VATS). Methods. A retrospective chart review was performed on all patients who were discharged with a diagnosis of empyema and community-acquired pneumonia over a 10-year period (1993–2002) at Texas Children’s Hospital in Houston, Texas. Data collected included demographic information, clinical presentation, radiographic studies, laboratory data including culture results, and hospital course. Results. A total of 230 charts were available for review. The mean age of the patients was 4.0 ± 3.6 years. Of the pleural fluid cultures performed, 32% (69 of 219) were positive. An additional 27 patients had a cause identified by blood culture. The first penicillin-nonsusceptible Streptococcus pneumoniae was identified in 1995, and the first methicillin-resistant Staphylococcus aureus was identified in 1998. After the universal use of the pneumococcal conjugate vaccine, 3 major changes have occurred (1999–2000 vs 2001–2002): 1) the number of patients admitted with empyema (per 10 000 admissions) has decreased from 23 to 12.6; 2) the prevalence of S pneumoniae has decreased from 66% (29 of 44) to 27% (4 of 15); and 3) S aureus has become the most common pathogen isolated (18% vs 60%), with 78% of those being methicillin resistant. The use of early VATS (<48 hours after admission) versus late VATS (>48 hours after admission) significantly decreased the length of hospitalization (11.49 ± 6.56 days vs 15.18 ± 8.62 days). Conclusions. The microbiologic cause of empyema has changed with an increasing incidence of S aureus, particularly methicillin-resistant S aureus. The use of VATS for initial therapy of empyema results in decreased duration of fever and length of hospitalization.

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology and Child Health

Reference31 articles.

1. Strange C. Pathogenesis and management of parapneumonic effusions and empyema. In: Feigin RD (ed). UpToDate Pediatrics. Wellesley, MA: UpToDate; 2001

2. Givan DC, Eigen H. Common pleural effusions in children. Clin Chest Med.1998;19:363–371

3. Rees JH, Spencer DA, Parikh D, Weller P. Increase in incidence of childhood empyema in West Midlands, UK. Lancet.1997;349:402

4. Playfor SD, Smyth AR, Stewart RJ. Increase in incidence of childhood empyema. Thorax.1997;52:932

5. Thompson A, Reid A, Shields M, Steen H, Taylor R. Increased incidence in childhood empyema thoracis in Northern Ireland. Ir Med J.1999;92:438

Cited by 178 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3